DC-LC3in-D5 [CAS 2868312-73-4]
Partner: MedChemexpress LLC
| CAS No: | 2868312-73-4 |
| Applications: | COVID-19-immunoregulation |
| MW: | 397.30 |
| Formula: | C19H22Cl2N2O3 |
| SMILES: | O=C1/C(C(CC(C2=C(Cl)C(Cl)=CC=C2)C1)=O)=C/NCCN3CCOCC3 |
| Purity: | 98.51 |
| Description: | DC-LC3in-D5 acts as an autophagy inhibitor by attenuating LC3B lipidation. DC-LC3in-D5 binds with LC3B. DC-LC3in-D5 disrupts the LC3B-LBP2 interaction with an IC50 of 200 nM. DC-LC3in-D5 may contribute to anti-HCV or combination researchs in cancer through inhibiting autophagy[1]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
